Namita A. Goyal
Experienced in Collagen VI-Related Myopathy

Dr. Namita A. Goyal

Neurology
UCI Health - Irvine
19200 Jamboree Road, Suite 4200, 
Irvine, CA 
Accepting New Patients

Experienced in Collagen VI-Related Myopathy
UCI Health - Irvine
19200 Jamboree Road, Suite 4200, 
Irvine, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Namita Goyal is a UCI Health neurologist with board certifications in neurology, electrodiagnostic medicine and neuromuscular medicine.

Dr. Goyal is rated as an Experienced provider by MediFind in the treatment of Collagen VI-Related Myopathy. Her top areas of expertise are Inclusion Body Myositis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myositis, and Primary Lateral Sclerosis.

Her clinical research consists of co-authoring 70 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
University of Chicago, Neurology Residency
Specialties
Neurology
Licenses
Psychiatry & Neurology in MA
Board Certifications
CA State Medical License 2012 - 2024
MA State Medical License 2006 - 2023
Hospital Affiliations
UCI Medical Center
Languages Spoken
English
Gender
Female
Awards
Top Doctor Award, Orange County Medical Association
AB Baker Teacher Award, American Academy of Neurology

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

UCI Health - Irvine
19200 Jamboree Road, Suite 4200, Irvine, CA 92612
Call: 714-456-2332

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to Evaluate the Efficacy and Safety of MN-166 (Ibudilast) Followed by Open-Label Extension Phase in Subjects With Amyotrophic Lateral Sclerosis
A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to Evaluate the Efficacy and Safety of MN-166 (Ibudilast) Followed by Open-Label Extension Phase in Subjects With Amyotrophic Lateral Sclerosis
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Drug
Study Drug: MN-166
Study Phase: Phase 2/Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of Fosigotifator in Subjects With Amyotrophic Lateral Sclerosis Followed by an Active Treatment Extension
A Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of Fosigotifator in Subjects With Amyotrophic Lateral Sclerosis Followed by an Active Treatment Extension
Enrollment Status: Terminated
Publish Date: August 01, 2025
Intervention Type: Drug
Study Drug: ABBV-CLS-7262
Study Phase: Phase 1
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
Intermediate-size Patient Population Expanded Access Protocol: Repeated Administration of Nurown® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Intermediate-size Patient Population Expanded Access Protocol: Repeated Administration of Nurown® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Enrollment Status: No_longer_available
Publish Date: April 23, 2024
Intervention Type: Biological
Influence of NT5c1A Antibodies on Disease Progression, Clinical Phenotype and Blood and Muscle Biomarkers in Sporadic Inclusion Body Myositis - A Prospective Evaluation (INSPIRE-IBM Study)
Influence of NT5c1A Antibodies on Disease Progression, Clinical Phenotype and Blood and Muscle Biomarkers in Sporadic Inclusion Body Myositis - A Prospective Evaluation (INSPIRE-IBM Study)
Enrollment Status: Active_not_recruiting
Publish Date: April 09, 2024
A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS
A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS
Enrollment Status: Completed
Publish Date: February 29, 2024
Intervention Type: Other, Biological
Study Phase: Phase 3
Open Label, Non-randomized Extension Trial to Assess Long Term Safety and Efficacy of Arimoclomol in Subjects With Amyotropic Lateral Sclerosis Who Have Completed the ORARIALS-01 Trial
Open Label, Non-randomized Extension Trial to Assess Long Term Safety and Efficacy of Arimoclomol in Subjects With Amyotropic Lateral Sclerosis Who Have Completed the ORARIALS-01 Trial
Enrollment Status: Terminated
Publish Date: August 24, 2023
Intervention Type: Drug
Study Drug: Arimoclomol
Study Phase: Phase 3
A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis
A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: August 24, 2023
Intervention Type: Drug
Study Phase: Phase 3
Phase 2B Study of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Phase 2B Study of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: November 29, 2022
Intervention Type: Drug
Study Drug: Memantine
Study Phase: Phase 2
Fluid Biomarkers With Deep Phenotyping in Patients With ALS
Fluid Biomarkers With Deep Phenotyping in Patients With ALS
Enrollment Status: Completed
Publish Date: December 16, 2021
A Phase 2 Pharmacodynamic Trial of Ezogabine (Retigabine) on Neuronal Excitability in Amyotrophic Lateral Sclerosis
A Phase 2 Pharmacodynamic Trial of Ezogabine (Retigabine) on Neuronal Excitability in Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: August 28, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
Enrollment Status: Completed
Publish Date: May 07, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 12 Less Clinical Trials

69 Total Publications

Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis.
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis.
Journal: Muscle & nerve
Published: April 21, 2025
View All 69 Publications
Similar Doctors
Experienced in Collagen VI-Related Myopathy
Dr. Perry B. Shieh
Neurology | Neuromusculoskeletal Medicine
Experienced in Collagen VI-Related Myopathy
Dr. Perry B. Shieh
Neurology | Neuromusculoskeletal Medicine

The Regents Of The University Of California

200 Ucla Medical Plz, Suite 120, 
Los Angeles, CA 
 (45.3 miles away)
310-206-6931
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Perry Shieh, MD is a Neurology Specialist in Los Angeles, CA and has over 22 years of experience in the medical field. He graduated from Johns Hopkins University School Of Medicine in 2000. He is affiliated with medical facilities Ronald Reagan UCLA Medical Center and Casa Colina Hospital. Dr. Shieh is rated as an Elite provider by MediFind in the treatment of Collagen VI-Related Myopathy. His top areas of expertise are Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Tubular Aggregate Myopathy.

Experienced in Collagen VI-Related Myopathy
Dr. Shalini Mahajan
Neurology
Experienced in Collagen VI-Related Myopathy
Dr. Shalini Mahajan
Neurology

R.S. Venuturupalli, M.D. Inc

8750 Wilshire Blvd, Suite 350, 
Beverly Hills, CA 
 (42.6 miles away)
310-652-0010
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shalini Mahajan is a Neurologist in Beverly Hills, California. Dr. Mahajan is rated as a Distinguished provider by MediFind in the treatment of Collagen VI-Related Myopathy. Her top areas of expertise are Myasthenia Gravis, Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, and Myositis.

Experienced in Collagen VI-Related Myopathy
Dr. Tahseen Mozaffar
Neurology
Experienced in Collagen VI-Related Myopathy
Dr. Tahseen Mozaffar
Neurology

UCI Health ALS & Neuromuscular Center

200 South Manchester Avenue, Suite 110, 
Orange, CA 
 (9.8 miles away)
714-456-2332
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Tahseen Mozaffar is a Professor of Neurology, Orthopaedic Surgery and Pathology and Laboratory Medicine at University of California, Irvine. He is the Director of the UC Irvine-MDA ALS and Neuromuscular Center and the Director of the Division of Neuromuscular Diseases. Dr. Mozaffar serves as chair of one of the biomedical committees and the institutional liaison for Trials Innovation Hub for the Center for Translational Sciences Award (CTSA) at University of California, Irvine. He is the Principal Investigator for UCI-NEXT, the NeuroNEXT award to the University of California, Irvine, one of 25 such NeuroNEXT sites funded by the NINDS/NIH.. Dr. Mozaffar is rated as an Elite provider by MediFind in the treatment of Collagen VI-Related Myopathy. His top areas of expertise are Pompe Disease, Inclusion Body Myositis, Myositis, Myasthenia Gravis, and Thymectomy.

VIEW MORE COLLAGEN VI-RELATED MYOPATHY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Goyal's expertise for a condition
ConditionClose
  • Elite
  • Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
    Dr. Goyal is
    Elite
    . Learn about Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).
    See more Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) experts
  • Inclusion Body Myositis
    Dr. Goyal is
    Elite
    . Learn about Inclusion Body Myositis.
    See more Inclusion Body Myositis experts
  • Myositis
    Dr. Goyal is
    Elite
    . Learn about Myositis.
    See more Myositis experts
  • Primary Lateral Sclerosis
    Dr. Goyal is
    Elite
    . Learn about Primary Lateral Sclerosis.
    See more Primary Lateral Sclerosis experts
  • Distinguished
  • Dermatomyositis
    Dr. Goyal is
    Distinguished
    . Learn about Dermatomyositis.
    See more Dermatomyositis experts
  • Myasthenia Gravis
    Dr. Goyal is
    Distinguished
    . Learn about Myasthenia Gravis.
    See more Myasthenia Gravis experts
  • Polymyositis
    Dr. Goyal is
    Distinguished
    . Learn about Polymyositis.
    See more Polymyositis experts
  • Spinal and Bulbar Muscular Atrophy
    Dr. Goyal is
    Distinguished
    . Learn about Spinal and Bulbar Muscular Atrophy.
    See more Spinal and Bulbar Muscular Atrophy experts
  • Spinal Muscular Atrophy (SMA)
    Dr. Goyal is
    Distinguished
    . Learn about Spinal Muscular Atrophy (SMA).
    See more Spinal Muscular Atrophy (SMA) experts
  • Spinal Muscular Atrophy Type 3
    Dr. Goyal is
    Distinguished
    . Learn about Spinal Muscular Atrophy Type 3.
    See more Spinal Muscular Atrophy Type 3 experts
  • Advanced
  • Cramp-Fasciculation Syndrome
    Dr. Goyal is
    Advanced
    . Learn about Cramp-Fasciculation Syndrome.
    See more Cramp-Fasciculation Syndrome experts
  • Dysarthria
    Dr. Goyal is
    Advanced
    . Learn about Dysarthria.
    See more Dysarthria experts
  • Facioscapulohumeral Muscular Dystrophy (FSHD)
    Dr. Goyal is
    Advanced
    . Learn about Facioscapulohumeral Muscular Dystrophy (FSHD).
    See more Facioscapulohumeral Muscular Dystrophy (FSHD) experts
  • Limb-Girdle Muscular Dystrophy
    Dr. Goyal is
    Advanced
    . Learn about Limb-Girdle Muscular Dystrophy.
    See more Limb-Girdle Muscular Dystrophy experts
  • Multifocal Motor Neuropathy
    Dr. Goyal is
    Advanced
    . Learn about Multifocal Motor Neuropathy.
    See more Multifocal Motor Neuropathy experts
  • Myoglobinuria Recurrent
    Dr. Goyal is
    Advanced
    . Learn about Myoglobinuria Recurrent.
    See more Myoglobinuria Recurrent experts
View All 9 Advanced Conditions
  • Experienced
  • Acute Cerebellar Ataxia
    Dr. Goyal is
    Experienced
    . Learn about Acute Cerebellar Ataxia.
    See more Acute Cerebellar Ataxia experts
  • Becker Muscular Dystrophy
    Dr. Goyal is
    Experienced
    . Learn about Becker Muscular Dystrophy.
    See more Becker Muscular Dystrophy experts
  • Behr Syndrome
    Dr. Goyal is
    Experienced
    . Learn about Behr Syndrome.
    See more Behr Syndrome experts
  • Brachial Plexopathy
    Dr. Goyal is
    Experienced
    . Learn about Brachial Plexopathy.
    See more Brachial Plexopathy experts
  • Chronic Inflammatory Demyelinating Polyneuropathy
    Dr. Goyal is
    Experienced
    . Learn about Chronic Inflammatory Demyelinating Polyneuropathy.
    See more Chronic Inflammatory Demyelinating Polyneuropathy experts
  • Chronic Polyradiculoneuritis
    Dr. Goyal is
    Experienced
    . Learn about Chronic Polyradiculoneuritis.
    See more Chronic Polyradiculoneuritis experts
View All 57 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved